PARAGARD (intrauterine copper contraceptive) IUD – Hormone Free Birth Control

Paragard (Intrauterine Copper Contraceptive) IUD

PARAGARD® (intrauterine copper contraceptive) is the only highly effective, reversible birth control that is completely hormone free.1 PARAGARD is a copper-releasing device (IUD) that is placed in the uterus to prevent pregnancy for up to 10 years. PARAGARD is made mostly of soft, flexible plastic and copper. PARAGARD is FDA approved for over 30 years and has been used by millions of women.

When you’re counseling, ask her: “hormones or hormone free?”

  • 56% of women reported that they had concerns with hormones in their birth control*2
  • 48% of women used them anyway because they were unaware of hormone-free choices*2
  • 43% of women were interested in learning about hormone-free options †
To Order PARAGARD
Visit PARAGARD Access Center to view a comprehensive range of support services and resources for ordering, including direct purchase, patient benefits verification service, fulfillment through our specialty pharmacy, as well as a solution for patients who choose to self-pay. hcp.paragard.com 1-877-PARAGARD

*Based on a September 2017 web-based survey of US women aged 18-45 years (N=300), where participants were asked about their attitudes about birth control that contains hormones. Respondents were required to be currently using birth control or have plans to use birth control in the next year. Repeat respondents within the previous 6 months were not permitted.
† Based on a 2016 web-based survey of US women aged 18-45 years (N=3020).

1 Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T‐380A contraceptive device. Int J Womens Health. 2010;2:211-220.
2 Data on file. Market research, July 2016. CooperSurgical, Inc.

Request Product Information

Parts & Accessories

Sign up to receive CooperSurgical's latest news and product info.
Need More Information?

To locate a sales representative, please enter a U.S. ZIP code below:

INDICATION

PARAGARD is indicated for intrauterine contraception for up to 10 years.

IMPORTANT SAFETY INFORMATION

  • Paragard must not be used by women who have acute pelvic inflammatory disease (PID); have had a postpregnancy or postabortion uterine infection in the past 3 months; have cancer of the uterus or cervix; have an infection of the cervix; have an allergy to any component; or have Wilson's disease.
  • If a woman misses her period, she must be promptly evaluated for pregnancy.
  • Possible serious complications that have been associated with intrauterine contraceptives are PID, embedment, perforation of the uterus, and expulsion.
  • Paragard must not be used by women who are pregnant as this can be life threatening and may result in loss of pregnancy or infertility.
  • The most common side effects of Paragard are bleeding and spotting; for most women, these typically subside after 2 to 3 months.
  • Paragard does not protect against HIV or other sexually transmitted infections (STI).

For full product information, please see the Full Prescribing Information.

References

1Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use; 2017.

2Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device. Int J Womens Health. 2010;2:211-220.

*According to the Centers for Disease Control and Prevention (CDC), Paragard is one of the least restrictive birth control options across all patient types compared to other IUDs.

IMPORTANT SAFETY INFORMATION

  • Paragard must not be used by women who have acute pelvic inflammatory disease (PID); have had a postpregnancy or postabortion uterine infection in the past 3 months; have cancer of the uterus or cervix; have an infection of the cervix; have an allergy to any component; or have Wilson's disease. continue reading
  • If a woman misses her period, she must be promptly evaluated for pregnancy. continue reading